Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Mar;69(3):691-694.
doi: 10.4103/ijo.IJO_3037_20.

Ophthalmic manifestations in the COVID-19 clinical spectrum

K Kiran Kumar  1 , U C Sampritha  1 , Akshata A Prakash  1 , Karishma Adappa  1 , S Chandraprabha  1 , T G Neeraja  1 , N S Guru Prasad  1 , Jessica Basumatary  1 , Suresh Babu Gangasagara  1 , B L Sujatha Rathod  1 , Chakravarthy Raghunathan Jayanthi  2
Affiliations
Observational Study

Ophthalmic manifestations in the COVID-19 clinical spectrum

K Kiran Kumar et al. Indian J Ophthalmol. 2021 Mar.

Abstract

Purpose: The aim of this study was to determine the frequency and various types of ophthalmic manifestation of patients with COVID-19.

Methods: This is a prospective observational study conducted on patients with SARS-Co-V-2 infection, at a dedicated tertiary COVID-19 hospital in South India from April 1 to July 31, 2020. At the time of their admission to the COVID hospital, demographic data such as name, age, sex was recorded. A thorough history regarding the onset, duration, progression, nature of symptoms and its associated factors, medication history, treatment history were elicited and documented. Ocular examination was performed under torchlight by an ophthalmologist posted for COVID duty. Further investigations including imaging were sought for, depending on clinical indications. Serial follow-up examinations of all patients were carried out every 72 hours or when patients complained of any ocular symptoms whichever earlier, until discharge. All relevant data were compiled and statistically analyzed.

Results: A total of 2742 patients were examined. Of them, 1461 (53.28%) were males and 1281 (46.72%) were females. The mean age (±SD) was 39.46 ± 17.63 years. None of the patients in our study had any ocular symptoms or signs as the presenting complaint at the time of their admission. On subsequent follow-up, only 20 (0.72%) developed ocular manifestations, of which 19 (95%) had features suggestive of Bilateral viral conjunctivitis. However, 1 (5%) patient had orbital cellulitis secondary to pansinusitis.

Conclusion: Ophthalmic manifestations in the clinical spectrum of COVID-19 infection are uncommon and unlikely to be the presenting clinical impression. However, it has broadened our view to a wider spectrum of COVID-19 presentations enhancing our clinical acumen for staunch detection of COVID-19 suspects in our daily practice, augmenting early diagnosis and management and also break the chain of transmission for the greater good of humanity.

Keywords: Conjunctivitis; SARS-Co-V-2; ophthalmic manifestations; orbital cellulitis.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
(a) Follicular conjunctivitis. (b) Follicular conjuctivitis
Figure 2
Figure 2
Case of orbital cellulitis showing lid edema, chemosis
See this image and copyright information in PMC

References

    1. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418–23. - PMC - PubMed
    1. Transmission of SARS-CoV-2: Implications for infection prevention precautions [Internet] Last cited on 2020 Jul 27. Available from: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-c... .
    1. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. StatPearls. Treasure Island (FL): StatPearls Publishing; 2020. Features, Evaluation and Treatment Coronavirus (COVID-19) [Internet] Last cited on 2020 Aug 03. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554776/ - PubMed
    1. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020;80:656–65. - PMC - PubMed
    1. Million M, Lagier J-C, Gautret P, Colson P, Fournier P-E, Amrane S, et al. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020;35:101738. - PMC - PubMed

Publication types